Dr. Ojodomo J. Achadu is a Senior Lecturer in Chemistry at the School of Health & Life Sciences at Teesside University. He holds a Ph.D. in Chemistry/Nanochemistry with an emphasis on nanomaterials chemistry and nanosensors/biosensors development. Dr. Achadu studied for his Ph.D. at the Institute for Nanotechnology Innovation, Rhodes University, South Africa. Dr. Achadu is a Topic Editor of Chemosensors and an editorial board member of the Science Communication Hub. He has published over 40 articles in leading scientific journals, including ACS Applied Materials & Interfaces, Biosensors and Bioelectronics, etc., as well as book chapters and conference presentations/contributions. He also serves as a reviewer of numerous scientific journals and a co-editor of published books.
Dr. Panagiota S Filippou is a Senior Lecturer of Biomedical Sciences and a Course Leader of the MSc Cancer and Molecular Diagnostics in the School of Health & Life Sciences at Teesside University. She gained her B.Sc. in Chemistry, M.Sc. in Biochemistry, and Ph.D. in Biochemistry at Aristotle University of Thessaloniki, Greece. Her main research interests include, among others, the identification of novel biomolecular signatures as cancer diagnostic biomarkers for brain cancer, etc. Furthermore, she is a member of the American Association for Cancer Research (AACR), the European Association of Cancer Research (EACR), the Metastasis Research Society (MRS), the Biochemical Society UK, and the International Cytokine & Interferon Society (ICIS).
Dr. Ahmad Adam Khundakar is a Senior Lecturer at Teesside University and Associate Lecturer at the Translational and Clinical Research Institute, Newcastle University. He earned his Bachelor's in Human Biology at Leeds Metropolitan University, his Master's in Neuroscience at the University of Manchester, and his Ph.D. in Applied Neuroscience at De Montfort University, in 1998, 2000 and 2004, respectively. He has a broad base of expertise in biomedical science and neuroscience and has published and presented extensively in neuropharmacology and neuropathology. Dr. Khundakar's research primarily involves investigating the molecular and pathological mechanisms underlying neurodegenerative illnesses, such as Alzheimer’s disease, dementia with Lewy bodies, Parkinson's disease, and depression.
